As age increases, the pancreas changes, which increases the risk of metabolic diseases such as type 2 diabetes, digestive ...

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE-MKT: SENS), a medical technology company focused on the development and commercialization of Eversense®, a long-term, implantable ...

A new device that researchers developed aims to bring a new artificial pancreas that is more suitable as an implant for the body, focusing on diabetic patients that need the organ. It claims to avoid ...

Adverse events (AEs) generally transient and readily manageable; only 2 cases of cytokine release syndrome (CRS)Prolonged tumor control with ...

Scientists at City of Hope, one of the largest and most advanced cancer research and treatment organizations in the U.S., and ...

– New data from PERIO-01 clinical trial indicates PEDD™ method resulted in modulation of the tumor microenvironment by enabling performance of the TLR9 agonist, SD-101, in metastatic uveal melanoma, ...

In a major development for diabetes care in India, Dr. Reddy's Labs has got the go-ahead from the Subject Expert Committee ...

Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma Our study included a broad cohort of ...